The secret to accessible weightloss is Found: Get your personalized GLP-1 plan
If you’ve been struggling to lose the stubborn weight that just won’t kick, I’m sure the thought of GLP-1 medications have crossed your mind a time or two.But, GLP-1s are expensive, and telehealth providers are often skeptical, with little understanding of what is best for your body.Found came up with a solution that makes weight loss not only more affordable, but more personal, so you have a credible, accessible option for metabolic care.Find the right treatment for you with a personalized plan that supports your long-term outcomes.
The individualized metabolic care program knows what your body needs and adapts with you overtime.Plus, Found offers a fast online eligibility check that helps members determine whether they can use insurance benefits toward GLP-1 medications.In fact, 1 in 3 Americans are able to use insurance coverage.You can start a GLP-1 now for $99 a month while Found is offering $100 off your first month.
Get access to 15+ FDA-approved brand-name and compounded medications such as Zepbound, Ozempic, Mounjaro, and more without sneaky hidden fees and with the same price at every dose level.Found’s eligibility check ensures you will have all the pricing facts ahead of time.Found then gets to know your body and routines through a pre-assessment that is reviewed by real clinicians.
They build a personalized plan for your needs to maximize efficacy and minimize side effects.Members have access to free shipping and unlimited clinician visits for on-going, long-term support.For over 200 years, the New York Post has been America’s go-to source for bold news, engaging stories, in-depth reporting, and now, insightful shopping guidance.
We’re not just thorough reporters – we sift through mountains of information, test and compare products, and consult experts on any topics we aren’t already schooled specialists in to deliver useful, realistic product recommendations based on our extensive and hands-on analysis.Here at The Post, we’re kno...